Treatment for Type-2-Diabetes News: Fixed Combination of DPP-4 and SGLT-2 Inhibitors

被引：0
|
作者：
不详
机构：
来源：
DIABETES STOFFWECHSEL UND HERZ | 2018年 / 27卷 / 03期
关键词：
TYPE-2; DIABETES-MELLITUS; MILLION PEOPLE; SITAGLIPTIN; THERAPY; RISK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：157 / 158
页数：2
相关论文
共 50 条
  • [21] Need for streamlined use of DPP-4 inhibitors in the treatment of type 2 diabetes
    Vitale, Cristiana
    Rosano, Giuseppe M. C.
    Prasad, Krishna
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [22] Will DPP-4 inhibitors replace sulfonylureas in the treatment of type 2 diabetes? Contra
    Mueller, U. A.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (11) : 547 - 547
  • [23] Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes
    Deacon, Carolyn F.
    PEPTIDES, 2018, 100 : 150 - 157
  • [24] SGLT2-Inhibitors - A Milestone in the Treatment of Patients with Type-2-Diabetes
    Preisker, S.
    NEPHROLOGE, 2020, 15 (06): : 368 - 371
  • [25] An update on DPP-4 inhibitors in the management of type 2 diabetes
    Cahn, Avivit
    Cernea, Simona
    Raz, Itamar
    EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (04) : 409 - 419
  • [26] Renoprotective Effect of Thai Patients with Type 2 Diabetes Mellitus Treated with SGLT-2 Inhibitors versus DPP-4 Inhibitors: A Real-World Observational Study
    Chanawong, Apichaya
    Uitrakul, Suriyon
    Incomenoy, Supatcha
    Poonchuay, Natnicha
    ADVANCES IN PHARMACOLOGICAL AND PHARMACEUTICAL SCIENCES, 2023, 2023
  • [27] A Clinical Overview of DPP-4 Inhibitors for Type 2 Diabetes
    Jeon, Michelle
    Took, Roxane L.
    Peters, Golden L.
    US PHARMACIST, 2018, 43 (10) : 49 - 56
  • [28] Efficacy/safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes
    Scheen, Andre J.
    DIABETES & METABOLISM, 2021, 47 (06)
  • [29] In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors
    Liakos, Aris
    Tsapas, Apostolos
    Bekiari, Eleni
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (12) : JC70 - JC70
  • [30] SGLT-2 Inhibitors and GLP-1-RA reduce Risk of NAFLD in Type-2-Diabetes
    不详
    DIABETOLOGIE UND STOFFWECHSEL, 2022, 17 (04) : 250 - 251
12345